Apricus Biosciences Inc (NASDAQ:APRI)

1.50
Delayed Data
As of May 21
 -0.06 / -3.85%
Today’s Change
0.92
Today|||52-Week Range
2.75
+50.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$78.6M

Company Description

Apricus Biosciences, Inc. is a pharmaceutical company focus on the development and commercialization of products and product candidates in the areas of specialty urology and rheumatology. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.

Contact Information

Apricus Biosciences, Inc.
11975 El Camino Real
San Diego California 92130
P:(858) 222-8041
Investor Relations:

Employees

Shareholders

Individual stakeholders6.62%
Mutual fund holders3.84%
Other institutional15.54%

Top Executives

Richard W. PascoeChief Executive Officer, Secretary & Director
Catherine BovenizerChief Accounting Officer & Vice President-Finance
Barbara TroupinChief Medical Officer & Senior Vice President
Brian T. DorseyChief Development Officer & Senior Vice President
Neil C. MortonVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account